235 related articles for article (PubMed ID: 25248617)
21. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
22. Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts.
Mesquita D; Barros-Silva JD; Santos J; Skotheim RI; Lothe RA; Paulo P; Teixeira MR
Oncotarget; 2015 Mar; 6(7):5217-36. PubMed ID: 25595908
[TBL] [Abstract][Full Text] [Related]
23. [Comparative analysis of gene expression in normal and cancer human prostate cell lines].
Rosenberg IeE; Herashchenko HV; Kashuba VI
Ukr Biochem J; 2014; 86(2):119-28. PubMed ID: 24868918
[TBL] [Abstract][Full Text] [Related]
24. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
25. Identification of PCAG1 as a novel prostate cancer-associated gene.
Lai Y; Yu Z; Wang Y; Ye J
Mol Med Rep; 2013 Mar; 7(3):755-60. PubMed ID: 23292432
[TBL] [Abstract][Full Text] [Related]
26. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
27. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer.
Wu L; Zhao JC; Kim J; Jin HJ; Wang CY; Yu J
Cancer Res; 2013 Oct; 73(19):6068-79. PubMed ID: 23913826
[TBL] [Abstract][Full Text] [Related]
28. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.
Nonn L; Vaishnav A; Gallagher L; Gann PH
Exp Mol Pathol; 2010 Feb; 88(1):45-51. PubMed ID: 19874819
[TBL] [Abstract][Full Text] [Related]
29. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.
Yamasaki M; Nomura T; Sato F; Mimata H
Oncol Rep; 2007 Nov; 18(5):1145-53. PubMed ID: 17914565
[TBL] [Abstract][Full Text] [Related]
30. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.
Zhang B; Chen H; Zhang L; Dakhova O; Zhang Y; Lewis MT; Creighton CJ; Ittmann MM; Xin L
Oncogene; 2014 Jun; 33(24):3099-108. PubMed ID: 23851498
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
[TBL] [Abstract][Full Text] [Related]
32. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.
Moiola CP; De Luca P; Zalazar F; Cotignola J; Rodríguez-Seguí SA; Gardner K; Meiss R; Vallecorsa P; Pignataro O; Mazza O; Vazquez ES; De Siervi A
Clin Cancer Res; 2014 Aug; 20(15):4086-95. PubMed ID: 24842953
[TBL] [Abstract][Full Text] [Related]
33. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.
Porkka KP; Helenius MA; Visakorpi T
Lab Invest; 2002 Nov; 82(11):1573-82. PubMed ID: 12429817
[TBL] [Abstract][Full Text] [Related]
35. Quantification of expression of netrins, slits and their receptors in human prostate tumors.
Latil A; Chêne L; Cochant-Priollet B; Mangin P; Fournier G; Berthon P; Cussenot O
Int J Cancer; 2003 Jan; 103(3):306-15. PubMed ID: 12471613
[TBL] [Abstract][Full Text] [Related]
36. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics.
Kristiansen G; Fritzsche FR; Wassermann K; Jäger C; Tölls A; Lein M; Stephan C; Jung K; Pilarsky C; Dietel M; Moch H
Br J Cancer; 2008 Sep; 99(6):939-48. PubMed ID: 18781151
[TBL] [Abstract][Full Text] [Related]
37. Ets-1 is implicated in the regulation of androgen co-regulator FHL2 and reveals specificity for migration, but not invasion, of PC3 prostate cancer cells.
Adler D; Langer B; Lindstrot A; Florin A; Bosserhoff A; Buettner R; Wernert N
Oncol Rep; 2011 Apr; 25(4):1125-9. PubMed ID: 21258770
[TBL] [Abstract][Full Text] [Related]
38. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
[TBL] [Abstract][Full Text] [Related]
39. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
40. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
